TR9.F OTRS AG (XETRA) trading €18.90 on 19 Mar 2026: intraday oversold bounce setup

TR9.F stock is trading at €18.90 on XETRA in Germany on 19 Mar 2026 during the intraday session, showing a thin-volume bounce setup after recent consolidation. Volume is very light at 10.00 shares versus an average of 550.00, which creates short-term directional risk but also an oversold bounce opportunity for nimble traders. We see support close to the 50-day average €18.27 and a longer-term reference at the 200-day average €14.79. This piece frames the trade setup, valuation, Meyka AI grading, and practical price targets for intraday risk management.

Intraday technical snapshot for TR9.F stock

On XETRA the price sits at €18.90 with day range equal to the current price and very low traded volume 10.00. Short-term indicators are muted on the feed, but price sitting near the 50-day average €18.27 signals a potential bounce zone for intraday mean-reversion trades. Market microstructure matters: low liquidity raises spreads and slippage risk for larger orders.

Fundamentals and valuation for TR9.F stock

OTRS AG shows trailing EPS -0.46 and a negative PE around -41.09, reflecting recent losses. Key ratios: price-to-sales 2.78, price-to-book 12.37, and current ratio 0.73, highlighting tight short-term liquidity. Market cap is approximately €36,218,051.00 with shares outstanding 1,916,299.00.

Sector comparison and TR9.F stock context

OTRS AG trades in Technology, Software – Application, where peers carry much higher forward multiples; the sector average PE is about 34.22, so TR9.F stock sits outside typical valuation peers due to negative earnings. Sector momentum is mixed, which increases company-specific sensitivity to product updates, contract wins, or security software demand.

Meyka AI rates TR9.F with a score out of 100 and forecast

Meyka AI rates TR9.F with a score out of 100: 65.27 (Grade: B) and suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 1-year target of €20.50, implying an upside of 8.47% from €18.90; forecasts are model-based projections and not guarantees.

Trade plan: intraday oversold bounce on TR9.F stock

For an oversold bounce strategy we set a tight intraday plan: buy limit near €18.27 (50-day mean) with stop-loss at €17.00 and an initial profit target at €20.50. Position sizing should reflect liquidity; with volume 10.00, keep sizes small to avoid market impact. Use VWAP and spread checks before entry.

Catalysts, risks and news to watch for TR9.F stock

Watch OTRS contract announcements, STORM cybersecurity sales cadence, and the next earnings date on 2024-10-31 for material moves. Key risks include thin liquidity, negative EPS, elevated price-to-book, and a low current ratio 0.73. For primary company information see OTRS website and the corporate LinkedIn page OTRS on LinkedIn.

Final Thoughts

Intraday traders looking at TR9.F stock face a classic thin-market oversold bounce setup. The stock trades at €18.90 on XETRA with very low volume 10.00, making any bounce sharp and short-lived unless confirmed by follow-through volume. Meyka AI’s model projects €20.50 in 12 months, an implied upside of 8.47% versus current price, but this is a model projection and not a guarantee. Practical intraday targets we discussed are stop-loss €17.00 and primary target €20.50, with a stretch target at €22.00 in a sustained recovery and a downside scenario to €15.00 if liquidity evaporates. Given negative EPS -0.46 and a negative PE, investors should treat trades as tactical rather than buy-and-hold ideas. Use small sizes, clear stops, and confirm with higher volume before committing. For our live quote and trade tools see TR9.F on Meyka: TR9.F on Meyka.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.